Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia
2020 ◽
Vol 104
(4)
◽
pp. 299-309
◽
1996 ◽
Vol 95
(2)
◽
pp. 281-290
◽
2017 ◽
Vol 178
(2)
◽
pp. 257-266
◽
2000 ◽
Vol 110
(1)
◽
pp. 139-146
◽
2016 ◽
Vol 176
(2)
◽
pp. 318-321
◽
2016 ◽
Vol 176
(2)
◽
pp. 248-257
◽